BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hippocampus
,
Anticancer prodrugs
,
Lipopolysaccharide
,
rs6983267
,
SLC12A1
,
Arthritis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
nkg2d receptor
Summary
General Info
Curated Studies
Most Correlated Studies
CD8+ T cells sorted NKG2D-positive or negative from lymph nodes of mice with alopecia
NK cell gene expression of expanded and non-expanded cells from healthy donors and myeloma patients
Natural killer (NK) cells from acute myeloid leukemia (AML) patients with defective NK-profiles
Colorectal cancer and squamous cell carcinoma cell lines treated with spironolactone
Leukemic cells from natural killer cell deficient acute myeloid leukemic (AML) patients
Explore Curated Studies Results
Literature
Most Relevant Literature
Development and characterization of a canine-specific anti-CD94 (KLRD-1) monoclonal antibody.
Role of NKG2D ligands and receptor in haploidentical related donor hematopoietic cell transplantatio…
NKG2D receptor activation drives primary graft dysfunction severity and poor lung transplantation ou…
Pseudorabies Virus Infection Causes Downregulation of Ligands for the Activating NK Cell Receptor NK…
Effect of 5-aminolevulinic acid on gene expression and presence of NKG2D receptor on NK cells.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Safety Study of Chimeric Antigen Receptor Modified T-cells Targeting NKG2D-Ligands
NKG2D CAR-NK Cell Therapy in Patients With Refractory Metastatic Colorectal Cancer
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Ch…
A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19
NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ